{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T18:08:48Z","timestamp":1755799728034,"version":"3.44.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["61\/5\/2008-BMS"],"award-info":[{"award-number":["61\/5\/2008-BMS"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1016\/j.intimp.2015.08.004","type":"journal-article","created":{"date-parts":[[2015,8,15]],"date-time":"2015-08-15T11:33:53Z","timestamp":1439638433000},"page":"785-793","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Therapeutic anti-NLGP monoclonal antibody for carcinoembryonic antigen expressing tumors is nontoxic to Swiss and BALB\/c mice"],"prefix":"10.1016","volume":"28","author":[{"given":"Arnab","family":"Das","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bipasa","family":"Mondal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anamika","family":"Bose","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaydip","family":"Biswas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rathindranath","family":"Baral","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Smarajit","family":"Pal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2015.08.004_bb0005","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1016\/j.intimp.2005.03.008","article-title":"Immunostimulatory neem leaf preparation acts as an adjuvant to enhance the efficacy of poorly immunogenic B16 melanoma surface antigen vaccine","volume":"5","author":"Baral","year":"2005","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.intimp.2015.08.004_bb0010","doi-asserted-by":"crossref","first-page":"4352","DOI":"10.1016\/j.vaccine.2008.06.048","article-title":"Neem leaf glycoprotein helps to generate carcinoembryonic antigen specific anti-tumor immune responses utilizing macrophage-mediated antigen presentation","volume":"26","author":"Sarkar","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.intimp.2015.08.004_bb0020","doi-asserted-by":"crossref","first-page":"e66501","DOI":"10.1371\/journal.pone.0066501","article-title":"Normalization of tumor microenvironment by neem leaf glycoprotein potentiates effector T cell functions and therapeutically intervenes in the growth of mouse sarcoma","volume":"8","author":"Barik","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.intimp.2015.08.004_bb0025","first-page":"10","article-title":"Dysregulation in immune functions is reflected in tumor cell cytotoxicity by peripheral blood mononuclear cells from head and neck squamous cell carcinoma patients","volume":"8","author":"Bose","year":"2008","journal-title":"Cancer Immun."},{"key":"10.1016\/j.intimp.2015.08.004_bb0030","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1128\/CVI.00499-10","article-title":"Neem leaf glycoprotein partially rectifies suppressed dendritic cell functions and associated T cell efficacy in patients with stage IIIB cervical cancer","volume":"18","author":"Roy","year":"2011","journal-title":"Clin. Vaccine Immunol."},{"key":"10.1016\/j.intimp.2015.08.004_bb0035","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1038\/cmi.2010.29","article-title":"Restoration of dysregulated CC chemokine signaling for monocyte\/macrophage chemotaxis in head and neck squamous cell carcinoma patients by neem leaf glycoprotein maximizes tumor cell cytotoxicity","volume":"7","author":"Chakraborty","year":"2010","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.intimp.2015.08.004_bb0040","doi-asserted-by":"crossref","first-page":"e47434","DOI":"10.1371\/journal.pone.0047434","article-title":"Neem leaf glycoprotein activates CD8+ T cells to promote therapeutic anti-tumor immunity inhibiting the growth of mouse sarcoma","volume":"8","author":"Mallick","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.intimp.2015.08.004_bb0045","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0110040","article-title":"Neem leaf glycoprotein prophylaxis transduces immune dependent stop signal for tumor angiogenic switch within tumor microenvironment","volume":"9","author":"Banerjee","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.intimp.2015.08.004_bb0050","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.intimp.2006.10.014","article-title":"Antibody response against neem leaf preparation recognizes carcinoembryonic antigen","volume":"7","author":"Sarkar","year":"2007","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.intimp.2015.08.004_bb0055","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1097\/CJI.0000000000000050","article-title":"A monoclonal antibody against neem leaf glycoprotein recognizes carcinoembryonic antigen (CEA) and restricts CEA expressing tumor growth","volume":"37","author":"Das","year":"2014","journal-title":"J. Immunother."},{"key":"10.1016\/j.intimp.2015.08.004_bb0060","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.imlet.2014.08.004","article-title":"Murine carcinoma expressing carcinoembryonic antigen-like protein is restricted by antibody against neem leaf glycoprotein","volume":"162","author":"Das","year":"2014","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.intimp.2015.08.004_bb0065","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.pharmthera.2007.10.001","article-title":"Tumor necrosis factor antagonist mechanisms of action: a comprehensive review","volume":"117","author":"Tracey","year":"2008","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.intimp.2015.08.004_bb0070","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1001\/jama.300.16.1887","article-title":"Safety-related regulatory actions for biologicals approved in the United States and the European Union","volume":"300","author":"Giezen","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.intimp.2015.08.004_bb0075","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/nrd3003","article-title":"The safety and side effects of monoclonal antibodies","volume":"9","author":"Hansel","year":"2010","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.intimp.2015.08.004_bb0080","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.intimp.2012.11.006","article-title":"Neem leaf glycoprotein is nontoxic to physiological functions of Swiss mice and Sprague Dawley rats: histological, biochemical and immunological perspectives","volume":"15","author":"Mallick","year":"2013","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.intimp.2015.08.004_bb0085","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1097\/01.cco.0000228734.32261.62","article-title":"Adverse effects of the humanized antibodies used as cancer therapeutics","volume":"18","author":"Klastersky","year":"2006","journal-title":"Curr. Opin. Oncol."},{"key":"10.1016\/j.intimp.2015.08.004_bb0090","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1002\/ptr.1948","article-title":"Pretreatment with Neem (Azadirachta indica) Leaf Preparation in Swiss Mice diminishes Leukopenia and enhances the Antitumor Activity of Cyclophosphamide","volume":"20","author":"Ghosh","year":"2006","journal-title":"Phytother. Res."},{"key":"10.1016\/j.intimp.2015.08.004_bb0095","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1159\/000211558","article-title":"Neem (Azadirachta Indica) leaf preparation prevents leukocyte apoptosis mediated by Cisplatin plus 5-fluorouracil treatment in Swiss Mice","volume":"55","author":"Ghosh","year":"2009","journal-title":"Chemotherapy"},{"key":"10.1016\/j.intimp.2015.08.004_bb0100","doi-asserted-by":"crossref","first-page":"9","DOI":"10.2165\/00063030-200519010-00002","article-title":"Alemtuzumab in the treatment of chronic lymphocytic leukaemia","volume":"19","author":"Robak","year":"2005","journal-title":"BioDrugs"},{"key":"10.1016\/j.intimp.2015.08.004_bb0105","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/sj.icb.7100062","article-title":"The advent of the cytokine storm","volume":"85","author":"Clark","year":"2007","journal-title":"Immunol. Cell Biol."},{"key":"10.1016\/j.intimp.2015.08.004_bb0110","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1080\/15476910801897433","article-title":"Monoclonal antibody first dose cytokine release syndromes \u2014 mechanisms and prediction","volume":"5","author":"Wing","year":"2008","journal-title":"J. Immunotoxicol."},{"key":"10.1016\/j.intimp.2015.08.004_bb0115","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1056\/NEJMoa063842","article-title":"Cytokine storm in a phase 1 trial of the anti-CD28 monoclonal antibody TGN1412","volume":"355","author":"Suntharalingam","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.intimp.2015.08.004_bb0120","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1002\/ijc.2910550118","article-title":"Interleukin-10 production by human carcinoma cell lines and its relationship to interleukin-6 expression","volume":"55","author":"Gastl","year":"1993","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.intimp.2015.08.004_bb0125","doi-asserted-by":"crossref","first-page":"4630","DOI":"10.4049\/jimmunol.172.7.4630","article-title":"Recruitment of STAT3 for production of IL-10 by colon carcinoma cells induced by macrophage derived IL-6","volume":"172","author":"Herbeuval","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2015.08.004_bb0130","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1007\/s10585-004-7705-z","article-title":"Carcinoembryonic antigen promotes tumor cell survival in liver through an IL-10-dependent pathway","volume":"21","author":"Jessup","year":"2004","journal-title":"Clin. Exp. Metastasis"},{"key":"10.1016\/j.intimp.2015.08.004_bb0135","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/j.1365-2249.1997.tb08331.x","article-title":"Colon carcinoma cell lines stimulate monocytes and lamina propria mononuclear cells to produce IL-10","volume":"110","author":"Kucharzik","year":"1997","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.intimp.2015.08.004_bb0140","doi-asserted-by":"crossref","first-page":"2658","DOI":"10.1002\/(SICI)1521-4141(199909)29:09<2658::AID-IMMU2658>3.0.CO;2-G","article-title":"IL-10 enhances NK cell proliferation, cytotoxicity and production of IFN-gamma when combined with IL-18","volume":"29","author":"Cai","year":"1999","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.intimp.2015.08.004_bb0145","doi-asserted-by":"crossref","first-page":"e21146","DOI":"10.1371\/journal.pone.0021146","article-title":"A novel anti-CEACAM5 monoclonal antibody, CC4, suppresses colorectal tumor growth and enhances NK cells-mediated tumor immunity","volume":"6","author":"Zheng","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.intimp.2015.08.004_bb0150","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1158\/1535-7163.1559.3.12","article-title":"A humanized monoclonal antibody to carcinoembryonic antigen, labetuzumed, inhibits tumor growth and sensitizes human medullary thyroid cancer xenografts to decarbazine chemotherapy","volume":"3","author":"Stein","year":"2004","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.intimp.2015.08.004_bb0155","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S146239940000168X","article-title":"Strategies for cancer therapy using carcinoembryonic antigen vaccines","volume":"2","author":"H\u00f6rig","year":"2000","journal-title":"Expert Rev. Mol. Med."},{"key":"10.1016\/j.intimp.2015.08.004_bb0160","doi-asserted-by":"crossref","first-page":"3919","DOI":"10.1158\/0008-5472.CAN-06-2112","article-title":"Expression of tumor-associated differentiation antigens, MUC1 glycoforms and CEA, in human thymic epithelial cells: implications for self-tolerance and tumor therapy","volume":"67","author":"Cloosen","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.intimp.2015.08.004_bb0165","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1038\/mt.2010.272","article-title":"T cells targeting carcinoembryonic antigen can mediate regression of metastatic colorectal cancer but induce severe transient colitis","volume":"19","author":"Parkhurst","year":"2011","journal-title":"Mol. Ther."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576915300631?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576915300631?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T00:43:36Z","timestamp":1755650616000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576915300631"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["S1567576915300631"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2015.08.004","relation":{},"ISSN":["1567-5769"],"issn-type":[{"type":"print","value":"1567-5769"}],"subject":[],"published":{"date-parts":[[2015,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapeutic anti-NLGP monoclonal antibody for carcinoembryonic antigen expressing tumors is nontoxic to Swiss and BALB\/c mice","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2015.08.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}